| Listed site | cro | both |
|---|
| Summary | Bioanalytical CRO specializing in PK/PD, biomarker, and spatial imaging services across discovery through Phase 3 clinical trials, with 20+ years of regulatory expertise. | Integrated CRO and CDMO specializing in nucleic acid therapeutics (ASOs, siRNA, sgRNA, aptamers) from lead identification through GMP manufacturing, with dual-site facilities in Petaluma, USA and Berlin, Germany. |
|---|
| Services | - LC-MS Bioanalysis (Small Molecule)
- Bioanalysis
- Biomarker Assays
- Pathology & Histology Services
- In Vivo PK / PD Studies
- GLP Toxicology
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Discovery Research
- Translational Research
- Regulatory Affairs
- In Vivo Efficacy Models
- Preclinical In Vivo Studies
- Target Identification & Validation
- Clinical Imaging Core Lab
- Ligand-Binding Bioanalysis (Large Molecule)
| - Bioinformatics & Data Science
- High-Throughput Screening
- Target Identification & Validation
- Discovery Research
- GLP Toxicology
- In Vivo PK / PD Studies
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- In Vitro Pharmacology
- Oligonucleotide Manufacturing
- Process Development
- CMC Analytical Development
- Technology Transfer
|
|---|
| Modalities | - Small Molecule
- Biologics (Monoclonal Antibodies)
- Antibody-Drug Conjugate (ADC)
- Oligonucleotide
- Peptide
| |
|---|
| Indications | Data not yet provided. | Data not yet provided. |
|---|
| Locations | - Headquarters, Colorado Springs, Colorado, United States
- Utah, Salt Lake City, Utah, United States
- France, Loos, Hauts-de-France, France
- Office, Salt Lake City, Utah, United States
- Office, Loos, Nord, France
- Salt Lake City, Salt Lake City, Utah, United States
- Loos, Loos, Hauts-de-France, France
| - Petaluma, Petaluma, California, USA
- Berlin, Berlin, Berlin, Germany
- Kulmbach, Kulmbach, Bavaria, Germany
|
|---|
| Certifications | Data not yet provided. | - GLP · Identifier: Statement of GLP Compliance (06 Dec 2024)
- GMP · Identifier: Certificate of GMP Compliance (Regierung von Oberfranken, 14 Oct 2024)
|
|---|
| Reviews | Review summary appears after site-level review signal gate opens. | Review summary appears after site-level review signal gate opens. |
|---|